V010-5617 Screening compound: 2,4-bis(3-fluorophenyl)-6-{4-[2-(morpholin-4-yl)ethyl]piperazin-1-yl}-2H-pyrazolo[3,4-d]pyrimidin-3-amine

V010-5617 Screening compound: 2,4-bis(3-fluorophenyl)-6-{4-[2-(morpholin-4-yl)ethyl]piperazin-1-yl}-2H-pyrazolo[3,4-d]pyrimidin-3-amine
V010-5617 Screening compound: 2,4-bis(3-fluorophenyl)-6-{4-[2-(morpholin-4-yl)ethyl]piperazin-1-yl}-2H-pyrazolo[3,4-d]pyrimidin-3-amine alternative view

Chemical Structure Depiction of ChemDiv screening compound V010-5617
2,4-bis(3-fluorophenyl)-6-{4-[2-(morpholin-4-yl)ethyl]piperazin-1-yl}-2H-pyrazolo[3,4-d]pyrimidin-3-amine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V010-5617

Molecular Formula

C27H30F2N8O (C27 H30 F2 N8 O)

Compound Name

2,4-bis(3-fluorophenyl)-6-{4-[2-(morpholin-4-yl)ethyl]piperazin-1-yl}-2H-pyrazolo[3,4-d]pyrimidin-3-amine

IUPAC name

24-bis(3-fluorophenyl)-6-{4-[2-(morpholin-4-yl)ethyl]piperazin-1-yl}-2H-pyrazolo[34-d]pyrimidin-3-amine

SMILES

Nc1c2c(-c3cc(F)ccc3)nc(N3CCN(CCN4CCOCC4)CC3)nc2nn1-c1cccc(F)c1

InChI

InChI=1S/C27H30F2N8O/c28-20-4-1-3-19(17-20)24-23-25(30)37(22-6-2-5-21(29)18-22)33-26(23)32-27(31-24)36-11-9-34(10-12-36)7-8-35-13-15-38-16-14-35/h1-6,17-18H,7-16,30H2

InChI Key

PHVYWOBVFJUUBB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14249504

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

520.59

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.477

Distribution Coefficient, logD

3.412

Water Solubility, LogSw

-3.90

Polar Surface Area

71.231

Acid Dissociation Constant (pKa)

19.71

Base Dissociation Constant (pKb)

6.61

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

37.00

V010-5617 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V010-5617 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V010-5617?
Check Price and Availability of V010-5617, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V010-5617 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V010-5617
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V010-5617
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V010-5617 available by request